Impact of coronary artery bypass grafting on survival after aortic valve replacement

a Division of Cardiac, Vascular and Thoracic Surgery, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, UK b Department of Epidemiology and Public Health, Queen's University Belfast, UK *Corresponding author. Tel.: +44 28 90633831; fax: +44 28 90312907. E-mail address : mark.jones{at}...

Full description

Saved in:
Bibliographic Details
Published in:Interactive cardiovascular and thoracic surgery Vol. 5; no. 3; pp. 327 - 330
Main Authors: Jones, J. Mark, Lovell, Deidre, Cran, Gordon W, MacGowan, Simon W
Format: Journal Article
Language:English
Published: England Eur Assoc Cardio Surg 01-06-2006
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:a Division of Cardiac, Vascular and Thoracic Surgery, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, UK b Department of Epidemiology and Public Health, Queen's University Belfast, UK *Corresponding author. Tel.: +44 28 90633831; fax: +44 28 90312907. E-mail address : mark.jones{at}royalhospitals.n-i.nhs.uk (J.M. Jones). Treatment of coronary artery disease by coronary artery bypass grafting (CABG) concurrently with aortic valve replacement (AVR) improves outcome but survival compared to isolated AVR remains uncertain, as does the role of the left internal mammary artery (LIMA) graft to the left anterior descending (LAD) artery. All 799 patients undergoing elective primary AVR, using the St. Jude Medical ® mechanical prosthesis, with or without CABG, between March 1986 and May 2000, were reviewed with 100% follow-up. Operative mortality was 1.6% in 574 patients undergoing isolated AVR, 2.6% in 78 patients undergoing combined AVR and CABG with LIMA to LAD grafting (LIMA-AVR), 6.25% in 64 patients receiving vein grafts only to circumflex or right coronary artery territories (Non-LAD VG-AVR) and 2.4% in 83 patients receiving vein grafts to vessels including the LAD (LAD VG-AVR). Cox regression analysis showed improved survival after AVR compared to LAD VG-AVR ( P =0.008), but with no significant difference to survival after LIMA-AVR ( P =0.18) and Non-LAD VG-AVR ( P =0.08). Multivariable regression analysis identified advanced age ( P <0.001), male sex ( P <0.001), absence of diabetes ( P =0.02), number of grafts performed during surgery ( P =0.04), non-congenital valvular pathology ( P =0.001) and regurgitant valve disease ( P =0.008) as independent predictors of reduced survival. LIMA-LAD grafting was not a significant variable in the multivariable model. Key Words: Aortic valve replacement; CABG surgery; Heart valve replacement; Survival analysis
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1569-9293
1569-9285
DOI:10.1510/icvts.2005.118349